Search results for: 'diseas visualization market size'

Conventional visualization methods that depend on two-dimensional (2D) medical images have been fraught with challenges such as difficulty in interpreting the information due to the static nature of the content and lack of availability of volumetric data. To address these limitations, imaging preferences of the medical community are shifting toward...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

2021 marked the beginning of the revival of meeting rooms and office spaces. As businesses prepare for the return to office, meeting rooms have seen growing technology investments to support hybrid work. Despite the headwinds from the impact of supply chain issues and component shortages which have triggered uneven sales cycles throughout 2021, the...

2021 marked the beginning of the revival of meeting rooms and office spaces. As businesses prepare for the return to office, meeting rooms have seen growing technology investments to support hybrid work. Despite the headwinds from the impact of supply chain issues and component shortages which have triggered uneven sales cycles throughout 2021, the...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

Concerns about climate change and carbon emissions have put enormous pressure on nations to reduce emissions and move toward carbon neutrality. Decarbonization of industry, transport, heating, and energy has become imperative, and stakeholders must act now to reach climate targets and prevent further damage to the environment. The global electro...

Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...